156 related articles for article (PubMed ID: 32856940)
1. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV.
Sutton SS; Magagnoli J; Hardin JW; Hsu LI; Beaubrun A; Majethia S; Cummings TH
Curr Med Res Opin; 2020 Oct; 36(10):1635-1642. PubMed ID: 32856940
[TBL] [Abstract][Full Text] [Related]
2. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
Hsu R; Brunet L; Fusco J; Beyer A; Prajapati G; Wyatt C; Wohlfeiler M; Fusco G
HIV Med; 2021 May; 22(5):325-333. PubMed ID: 33247876
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
Kim JE; Scherzer R; Estrella MM; Ix JH; Shlipak MG
AIDS; 2016 Apr; 30(7):1049-57. PubMed ID: 26760455
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
LaFleur J; Bress AP; Esker S; Knippenberg K; Crook J; Nyman H; Bedimo R; Tebas P; Rosenblatt L
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):325-330. PubMed ID: 29210830
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease.
Mizushima D; Nguyen DTH; Nguyen DT; Matsumoto S; Tanuma J; Gatanaga H; Trung NV; van Kinh N; Oka S
J Infect Chemother; 2018 Jul; 24(7):549-554. PubMed ID: 29602711
[TBL] [Abstract][Full Text] [Related]
7. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
Bedimo R; Maalouf NM; Zhang S; Drechsler H; Tebas P
AIDS; 2012 Apr; 26(7):825-31. PubMed ID: 22301411
[TBL] [Abstract][Full Text] [Related]
8. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients.
Chen R; Scherzer R; Hsue PY; Jotwani V; Estrella MM; Horberg MA; Grunfeld C; Shlipak MG
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438737
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease, cardiovascular disease, and osteoporotic fractures in patients with and without HIV in the US Veteran's Affairs Administration System.
Sutton SS; Magagnoli J; Cummings TH; Hardin JW; Edun B; Beaubrun A
Curr Med Res Opin; 2019 Jan; 35(1):117-125. PubMed ID: 30378450
[No Abstract] [Full Text] [Related]
10. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S
Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648
[TBL] [Abstract][Full Text] [Related]
11. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea.
Kim E; Lee HW; Kim SS; Yoon E; Jang ES; Chang JI; Cho YY; Seo GH; Kim HJ
Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1185-1193. PubMed ID: 37694558
[TBL] [Abstract][Full Text] [Related]
13. Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults.
Agbaji OO; Abah IO; Ebonyi AO; Gimba ZM; Abene EE; Gomerep SS; Falang KD; Anejo-Okopi J; Agaba PA; Ugoagwu PO; Agaba EI; Imade GE; Sagay AS; Okonkwo P; Idoko JA; Kanki PJ
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821963. PubMed ID: 30672363
[TBL] [Abstract][Full Text] [Related]
14. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database.
García MG; Larrinaga-Torrontegui U; Eduardo Martinez E; Lertxundi U; Palacios-Zabalza I; Aguirre C
Am J Ther; 2019; 26(5):e589-e592. PubMed ID: 29324463
[TBL] [Abstract][Full Text] [Related]
15. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J
PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989
[TBL] [Abstract][Full Text] [Related]
16. Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients.
Yang J; Chen J; Ji Y; Tang Q; Zhang R; Liu L; Shen Y; Xun J; Song W; Tang Y; Wang Z; Qi T; Lu H
Int J Infect Dis; 2019 Jun; 83():64-71. PubMed ID: 30951879
[TBL] [Abstract][Full Text] [Related]
17. Determinants and Incidence of Chronic Kidney Disease with Tenofovir- Based Antiretroviral Therapy Regimens: A Cohort Study in HIV-Infected Adults in South China.
Liu F; Wang Y; Liu H; Chen C; Miao LB; Li ZY; Wang MC; Huang JS; Bao JF
Curr HIV Res; 2022; 20(3):242-250. PubMed ID: 36111752
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with fractures in HIV-infected persons: which factors matter?
Gedmintas L; Wright EA; Dong Y; Lehmann E; Katz JN; Solomon DH; Losina E
Osteoporos Int; 2017 Jan; 28(1):239-244. PubMed ID: 27421978
[TBL] [Abstract][Full Text] [Related]
19. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
Scherzer R; Gandhi M; Estrella MM; Tien PC; Deeks SG; Grunfeld C; Peralta CA; Shlipak MG
AIDS; 2014 Jun; 28(9):1289-95. PubMed ID: 24922479
[TBL] [Abstract][Full Text] [Related]
20. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
